PHEBRA POTASSIUM PHOSPHATE CONCENTRATED Injection

Država: Australija

Jezik: engleski

Izvor: Department of Health (Therapeutic Goods Administration)

Aktivni sastojci:

monobasic potassium phosphate, Quantity: 109.33 mg/mL; dibasic potassium phosphate, Quantity: 105.33 mg/mL

Dostupno od:

Phebra Pty Ltd

Farmaceutski oblik:

Injection, intravenous infusion

Sastav:

Excipient Ingredients: water for injections

Administracija rute:

Intravenous

Jedinice u paketu:

10mL x 10

Tip recepta:

Not scheduled. Not considered by committee

Terapijske indikacije:

INDICATIONS AS AT 01 JANUARY 1991 : Treatment of severe hypophosphataemia (serum levels <0.3mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. Lowering the pH of urine. The treatment of potassium depletion in patients with hypokalemia. IV administration is indicated when the patient is unable to take potassium orally or if hypokalemia is severe.

Proizvod sažetak:

Visual Identification: Clear colourless solution; Container Type: Vial; Container Material: Glass; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Status autorizacije:

Registered

Datum autorizacije:

1991-10-14